🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multicenter trial conducted in Pharmacy retail centers...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2012-11
Trial ID
NCT01726270
Treatments Being Tested
Open-label, 6 month-treatment with the IP in all subjects. - Sample size: A...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-06-29
Trial ID
NCT01673490
Treatments Being Tested
Urolithiasis is a disease that effects 12% of the population and its incide...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2008-01
Trial ID
NCT00382265
Treatments Being Tested
The purpose of this study is to evaluate the therapeutic efficacy of tamsul...
Status
Unknown
Location
University hospital of Splity
Start Date
2022-09-01
Trial ID
NCT05537272
Treatments Being Tested
The purpose of this study is to determine if tamsulosin ("FLOMAX") is effec...
Status
Completed
Location
University of Wisconsin Hospital and Clinics
Start Date
2015-08
Trial ID
NCT02486653
Treatments Being Tested
To date, there is a lack of consensus concerning the optimal timing for rem...
Status
Unknown
Location
Asan Medical Center
Start Date
2010-04
Trial ID
NCT01209988
Treatments Being Tested
The purpose of this study is to see if avanafil causes any changes in blood...
Status
Completed
Location
MDS Pharma Services Inc.,
Start Date
2010-02
Trial ID
NCT01100021
Treatments Being Tested
An open-label, randomized, single-dose crossover study to evaluate the phar...
Status
Completed
Location
Korea University Anam Hospital
Start Date
2018-12-19
Trial ID
NCT04084197
The aim of this work is to compare between early (3days) and late(7days) re...
Status
Completed
Location
Faculty of medicine ,Al Azhar university
Start Date
2017-03-12
Trial ID
NCT03280420
Treatments Being Tested
Multiple sclerosis (MS) is the leading non-traumatic cause of severe acquir...
Status
Unknown
Location
CHU de Nîmes
Start Date
2022-10-05
Trial ID
NCT05439902
Treatments Being Tested